Journal article

Formulation and Evaluation of Curcumin in Inclusion Complex using Beta Cyclodextrin

MCMrynal Chamoli1 MKMohammed Junaid Khan2 AKAtul Arunrao Kulkarni3 TRThirumalaikumaran Rathinam4 ADAvula Dhamini5 TDTushar Pradip Dukre6 VKVikas Kumar7 SDSaurabh Dave8*
Year2024
Volume20
Issue7
Pages1781-1789

Abstract

Turmeric (Curcuma longa L.) has a naturally occurring yellow substance called curcumin. However, in vitro tests have demonstrated a number of outstanding pharmacological properties, including anti-inflammatory, anti-tumor, antimicrobial, and antioxidant properties. Because beta-cyclodextrin (BCD) has advantages like improving drug release and/or permeation and stabilising drugs in the formulation or at the absorptive site, it is crucial to use BCD to form
inclusion complexes that will increase curcumin's ability to penetrate the membrane upon transdermal administration. Curcumin and beta-CD inclusion complexes were made using a solvent evaporation technique with mole ratios of
1:1, 1:2, and 2:1. Using physical characterisation of X-ray diffraction, differential scanning calorimetry, and a scanning electron microscope, the solids of the curcumin inclusion complex that produced the beta-CD were compared to the curcumin single component, beta-CD, and a physical mixture of curcumin-beta- CD. Curcumin-beta-CD inclusion complex formation is indicated by a mole ratio of 1:2, according to physical characterisation data. Curcumin-beta-CD is utilised in inclusion complexes to improve the stability and solubility of curcumin.

Cite this article

Citation data